Outcomes in patients with refractory/relapsed CNS lymphoma treated in complete remission: autologous transplantation vs. CAR-T therapy

Abstract Background Autologous hematopoietic cell transplantation (ASCT) is a reasonable consolidation therapy for eligible patients with chemosensitive relapsed central nervous system lymphoma (CNSL) who have achieved complete remission (CR) and maintained the CR. Chimeric antigen receptor T-cell (...

Полное описание

Библиографические подробности

Главные авторы:	Fan Yang, Rui Liu, Zhonghua Fu, Yuelu Guo, Lixia Ma, Miaomiao Cao, Biping Deng, Haifeng Wu, Chen Chen, Xiaoyan Ke, Kai Hu
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Springer 2026-03-01
Серии:	Cancer Immunology, Immunotherapy
Предметы:	Refractory/relapsed central nervous system lymphoma (R/R CNSL) Autologous transplantation (ASCT) Chimeric antigen receptor T-cell (CAR-T) therapy Consolidation therapy
Online-ссылка:	https://doi.org/10.1007/s00262-026-04334-x
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!